What NeuBase Therapeutics, Inc.'s executives and directors are doing with their own shares, from SEC Form 3/4/5 filings — separating what the filings state (awards, withholding, disclosed plans) from what only the pattern of dates shows.
| 3 months | 12 months | |
|---|---|---|
| Open-market buys | 0 | 0 |
| Sells | 0 | 0 |
| Total trades | 0 | 0 |
| 3 months | 12 months | |
|---|---|---|
| Acquired | 0 | 0 |
| Disposed | 0 | 0 |
| Net activity | +0 | +0 |
View rich charts and dive into the patterns of specific insiders — who is accumulating, who is winding down, and which sale explanations the filings actually support.
| Insider | Relation | Date | Transaction | Shares | Price | Value | Shares held |
|---|---|---|---|---|---|---|---|
| Symetryx Corp | 10% owner | Sep 18 | Open-market sale · S | −50,000 | $1.19 | −$59.5K | 0 |
| Symetryx Corp | Insider | Sep 18 | Other Transaction · J | +0 | — | — | 192,481 |
| Symetryx Corp | 10% owner | Sep 15 | Open-market sale · S | −103,337 | $1.26 | −$130K | 50,000 |
| Symetryx Corp | 10% owner | Sep 14 | Open-market sale · S | −129,108 | $1.44 | −$186K | 153,337 |
| Symetryx Corp | 10% owner | Sep 11 | Open-market sale · S | −3,376 | $1.44 | −$4.86K | 472,926 |
| Symetryx Corp | 10% owner | Sep 08 | Open-market sale · S | −128,847 | $1.53 | −$197K | 476,302 |
| Symetryx Corp | 10% owner | Sep 07 | Open-market sale · S | −74,852 | $1.80 | −$135K | 605,149 |
| Symetryx Corp | 10% owner | Sep 01 | Open-market buy · P | +61,076 | $0.98 | +$59.7K | 680,081 |
| Stephan Dietrich A | Founder and CEO | Aug 02 | Exercise / conversion · M | +93,234 | $0.02 | +$2.05K | 93,234 |
| Branning Todd P. | Chief Financial Officer | Mar 16 | Grant / award · A | +54,200 | — | — | 84,200 |
| Stephan Dietrich A | CEO and Director | Mar 16 | Grant / award · A | +153,000 | — | — | 153,000 |
| Stephan Dietrich A | President and CEO | Feb 13 | Exercise / conversion · M | +655,000 | — | — | 1,471,775 |
| Stephan Dietrich A | CEO | Sep 28 | Exercise / conversion · M | +750,000 | $0.00 | +$825 | 816,775 |
| Mann William Roland | Chief Operating Officer | Mar 30 | Open-market buy · P | +6,200 | $1.92 | +$11.9K | 11,200 |
| Branning Todd P. | Chief Financial Officer | Mar 18 | Open-market buy · P | +10,000 | $1.81 | +$18.1K | 30,000 |
| Branning Todd P. | Chief Financial Officer | Mar 17 | Open-market buy · P | +10,000 | $1.74 | +$17.4K | 20,000 |
| Branning Todd P. | Chief Financial Officer | Mar 16 | Open-market buy · P | +10,000 | $1.62 | +$16.2K | 10,000 |
| Richman Eric I | Director | Mar 04 | Open-market buy · P | +1,000 | $1.62 | +$1.62K | 44,960 |
| Richman Eric I | Director | Mar 03 | Open-market buy · P | +1,300 | $1.72 | +$2.24K | 43,960 |
| Richman Eric I | Director | Mar 01 | Open-market buy · P | +1,580 | $1.58 | +$2.5K | 42,660 |
Loading...
